Cizzle Biotechnology Holdings PLC

Cizzle Biotechnology Holdings Plc is a cancer diagnostics company based in London, United Kingdom, operating with its subsidiaries. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.